β-Secretase (BACE) as a drug target for alzheimer’s disease
Top Cited Papers
- 1 December 2002
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 54 (12) , 1589-1602
- https://doi.org/10.1016/s0169-409x(02)00157-6
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Prodomain Processing of Asp1 (BACE2) Is AutocatalyticPublished by Elsevier ,2001
- Mechanism of Inhibition of β-Site Amyloid Precursor Protein-cleaving Enzyme (BACE) by a Statine-based PeptidePublished by Elsevier ,2001
- A Splice Variant of β-Secretase Deficient in the Amyloidogenic Processing of the Amyloid Precursor ProteinPublished by Elsevier ,2001
- Coordinated Expression of β‐Amyloid Precursor Protein and the Putative β‐Secretase BACE and α‐Secretase ADAM10 in Mouse and Human BrainJournal of Neurochemistry, 2000
- Modeling of substrate specificity of the Alzheimer’s disease amyloid precursor protein β-secretase 1 1Edited by F. E. CohenJournal of Molecular Biology, 2000
- Identification of a Novel Aspartic Protease (Asp 2) as β-SecretaseMolecular and Cellular Neuroscience, 1999
- BACE Maps to Chromosome 11 and a BACE Homolog, BACE2 , Reside in the Obligate Down Syndrome Region of Chromosome 21Science, 1999
- Amyloid β-peptide is produced by cultured cells during normal metabolismNature, 1992
- Amyloid β Protein Gene: cDNA, mRNA Distribution, and Genetic Linkage Near the Alzheimer LocusScience, 1987
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984